Kestra Advisory Services LLC Has $2.90 Million Stock Position in Cardinal Health, Inc. $CAH

Key Points

• Kestra Advisory Services LLC has increased its stake in Cardinal Health, Inc. by 23.5%, owning a total of 21,064 shares valued at approximately $2.9 million as of the latest SEC filing.
• Several institutional investors have also raised their positions in Cardinal Health, including JPMorgan Chase & Co. with a 40.0% increase, bringing its total holdings to over $575 million.
• Cardinal Health declared a quarterly dividend of $0.5107 per share, with an ex-dividend date of October 1st, representing a dividend yield of 1.4%.

Kestra Advisory Services LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 23.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 21,064 shares of the company's stock after purchasing an additional 4,007 shares during the quarter. Kestra Advisory Services LLC's holdings in Cardinal Health were worth $2,902,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. JPMorgan Chase & Co. grew its position in shares of Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Northern Trust Corp grew its position in shares of Cardinal Health by 3.5% in the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock valued at $433,012,000 after purchasing an additional 105,154 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Cardinal Health by 4.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock valued at $274,599,000 after purchasing an additional 94,768 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Cardinal Health by 3.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company's stock valued at $227,877,000 after purchasing an additional 52,714 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares of the company's stock, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider directly owned 14,976 shares of the company's stock, valued at $2,228,728.32. This represents a 47.41% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 271,676 shares of company stock worth $40,489,525. Corporate insiders own 0.09% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on CAH. Argus set a $189.00 target price on shares of Cardinal Health in a research note on Friday, August 22nd. Robert W. Baird increased their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Wall Street Zen cut shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Leerink Partners reduced their target price on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research note on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $165.93.

Cardinal Health Stock Up 0.7%

CAH stock traded up $1.03 during trading on Tuesday, hitting $149.81. The company had a trading volume of 801,005 shares, compared to its average volume of 2,419,985. The firm has a 50-day moving average price of $157.10 and a 200-day moving average price of $146.46. Cardinal Health, Inc. has a 12 month low of $106.54 and a 12 month high of $168.44. The stock has a market cap of $35.77 billion, a price-to-earnings ratio of 23.22, a PEG ratio of 1.26 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. During the same quarter in the previous year, the company posted $1.84 EPS. Cardinal Health's revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's payout ratio is currently 31.63%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.